ZAFFERANO-PHARMA®
Crocus sativus — Italian genetic line.
Italian-origin counterpart to SAFFRON-PHARMA®. Same species, distinct origin claim, distinct supply chain — one R&D framework with two genetic-and-geographic origin offerings for buyers requiring origin diversity.
ZAFFERANO-PHARMA® is the Italian-origin counterpart to the SAFFRON-PHARMA® Moldovan line. Same species — Crocus sativus — operating in Italian agroclimatic conditions with distinct genetic origin and distinct supply chain. The two programmes are not competing brands; they are one R&D framework offering two origin claims with different regulatory and commercial profiles.
Operational scope
The Italian line operates as a parallel cultivation and standardisation programme. Detailed operational specifics — hectares under cultivation, harvest cycles, processing capacity — are made available to qualifying partners under NDA.
Strategic rationale
Pharmaceutical and nutraceutical buyers often require origin diversity for risk-management, market-specific labelling, or quality-tier differentiation. The combined SAFFRON-PHARMA® / ZAFFERANO-PHARMA® offering allows a single supply relationship to address both procurement requirements without splitting it across unrelated suppliers.
Engagement
contact@tehnofarm.md. Subject line: ZAFFERANO-PHARMA® inquiry.